Skip to content
Home / Companies / ROIV ROI
Roivant Sciences Ltd. (ROIV) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest ROIV Insider Trades
About Roivant Sciences Ltd. (ROIV) Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Headquarters LONDON
Employees 721
Listed 2021
Exchange XNAS https://www.roivant.com SEC filings for ROIV on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 31 6,942,239 $240.36M Grant or award 3 1,723 Option exercise 25 4,855,500
ROIV Insider Transactions (Form 4) 113 119 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Mar 31, 2026 FT Frank Torti - Officer Tax withholding / forfeiture Common Shares 160,035
Recent ROIV Form 8-K Filings 5
Recent ROIV Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 28, 2026 Venker Eric Officer 200,000 $7.15M View on EDGAR Aug 21, 2026 MAYUKH SUKHATME Officer, Director
ROIV Insider Trading - FAQ
What is the latest insider trade for ROIV? Roivant Sciences Ltd. (ROIV) had 20 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for ROIV runs to 119 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ROIV stock? No insider purchases of ROIV were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ROIV stock? 31 insider sales of ROIV were filed in the last 90 days, totaling $240.36M.
Where can I see ROIV SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ROIV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ROIV insider buys? Create a free InsiderAlpha account and press Watch on this page to add ROIV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Aug 25, 2026 - Richard Pulik view on EDGAR Aug 25, 2026 - Eric Venker view on EDGAR Aug 22, 2026 - Mayukh Sukhatme view on EDGAR Aug 19, 2026 - Mayukh Sukhatme view on EDGAR Jul 30, 2026 - Eric Venker view on EDGAR Jul 22, 2026 - James C. Momtazee view on EDGAR Jul 22, 2026 - Melissa B, Epperly view on EDGAR Jul 22, 2026 - Ilan Oren view on EDGAR Jul 2, 2026 - Matthew Gline view on EDGAR
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ROIV insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 21, 2026
EV Eric Venker - Officer Open-market sale $6.99M
Jul 27, 2026
Market cap $25.07B
P/E ratio -
Dividend yield -
Average volume 5.62M
52 week high $37.97
52 week low $11.85
Today's high $37.13
Today's low $34.69
Open $37.01
Volume 8.76M
Previous close $37.58
Shares outstanding 722.32M Market cap
$25.07B
721 employees
ROIV Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 31 sales totaling $240.36M.
Most-Active ROIV Insiders - Last 90 Days 10 Tax withholding / forfeiture 7 188,728
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Mar 30, 2026 MG Matthew Gline - Officer Option exercise Common Shares 97,319 - -
Mar 30, 2026 MG Matthew Gline - Officer Tax withholding / forfeiture Common Shares 53,826 $26.41 $1.42M
Mar 31, 2026 MG Matthew Gline - Officer Tax withholding / forfeiture Common Shares 304,684 $27.70 $8.44M
Mar 30, 2026 MG Matthew Gline - Officer Option exercise Capped Value Appreciation Rights 2,178,150 $11.50 $25.05M
Mar 30, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 58,391 - -
Mar 30, 2026 MS Mayukh Sukhatme - Officer Tax withholding / forfeiture Common Shares 29,809 $26.41 $787K
Mar 31, 2026 MS Mayukh Sukhatme - Officer Tax withholding / forfeiture Common Shares 187,512 $27.70 $5.19M
Mar 30, 2026 MS Mayukh Sukhatme - Officer Option exercise Capped Value Appreciation Rights 1,306,889 $11.50 $15.03M
Mar 26, 2026 MF Meghan Fitzgerald Option exercise Stock Option (Right to Buy) 70,000 $0.00 -
Mar 20, 2026 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares 1,546 $27.70 $43K
Mar 20, 2026 JH Jennifer Humes - Officer Tax withholding / forfeiture Common Shares 14,526 $27.70 $402K
Mar 17, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Mar 17, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $28.24 $5.65M
Mar 17, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Mar 16, 2026 ME Melissa B, Epperly - Director Open-market sale Common Shares 41,861 $28.68 $1.20M
Feb 20, 2026 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares 1,000 $27.15 $27K
Feb 20, 2026 EV Eric Venker - Officer Tax withholding / forfeiture Common Shares 7,051 $27.15 $191K
Feb 19, 2026 FT Frank Torti - Officer Option exercise Common Shares 1,400,000 $3.85 $5.39M
Feb 20, 2026 FT Frank Torti - Officer Option exercise Common Shares 1,012,610 $3.85 $3.90M
Feb 23, 2026 FT Frank Torti - Officer Option exercise Common Shares 587,390 $3.85 $2.26M
Feb 19, 2026 FT Frank Torti - Officer Option exercise Stock Option (Right to Buy) 1,400,000 $0.00 -
Feb 19, 2026 FT Frank Torti - Officer Open-market sale Common Shares 1,400,000 $27.42 $38.39M
Feb 20, 2026 FT Frank Torti - Officer Open-market sale Common Shares 1,012,610 $27.15 $27.49M
Feb 23, 2026 FT Frank Torti - Officer Open-market sale Common Shares 587,390 $27.51 $16.16M
Feb 20, 2026 FT Frank Torti - Officer Option exercise Stock Option (Right to Buy) 1,012,610 $0.00 -
Feb 23, 2026 FT Frank Torti - Officer Option exercise Stock Option (Right to Buy) 587,390 $0.00 -
Feb 13, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Feb 13, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $26.49 $5.30M
Feb 13, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Feb 9, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 651,558 $12.68 $8.26M
Feb 9, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 651,558 $0.00 -
Feb 9, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 339,441 $26.47 $8.99M
Feb 9, 2026 MS Mayukh Sukhatme - Officer Other Common Shares 312,117 $26.47 $8.26M
Jan 20, 2026 IO Ilan Oren Grant or award Common Shares 1,164 $0.00 -
Jan 20, 2026 IO Ilan Oren Tax withholding / forfeiture Common Shares 124 $22.98 $3K
Jan 12, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Jan 12, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $21.92 $4.38M
Jan 12, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Dec 29, 2025 MS Mayukh Sukhatme - Officer Option exercise Common Shares 748,358 $12.68 $9.49M
Dec 31, 2025 MS Mayukh Sukhatme - Officer Option exercise Common Shares 2,449,877 $12.68 $31.06M
Dec 29, 2025 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 311,873 $21.74 $6.78M
Dec 29, 2025 MS Mayukh Sukhatme - Officer Other Common Shares 436,485 $21.74 $9.49M
Dec 31, 2025 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 1,018,995 $21.71 $22.12M
Dec 31, 2025 MS Mayukh Sukhatme - Officer Other Common Shares 1,430,882 $21.71 $31.06M
Dec 29, 2025 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 748,358 $0.00 -
Dec 31, 2025 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 2,449,877 $0.00 -
Dec 23, 2025 FT Frank Torti - Officer Grant or award Common Shares 175,380 $22.45 $3.94M
Dec 24, 2025 FT Frank Torti - Officer Other Common Shares 64,891 $22.47 $1.46M
Dec 24, 2025 FT Frank Torti - Officer Gift Common Shares 110,489 $0.00 -
Dec 23, 2025 RP Richard Pulik - Officer Option exercise Common Shares 260,000 $3.85 $1.00M
Dec 23, 2025 RP Richard Pulik - Officer Open-market sale Common Shares 260,000 $22.45 $5.84M
Dec 23, 2025 RP Richard Pulik - Officer Open-market sale Common Shares 146,731 $22.39 $3.29M
Dec 23, 2025 RP Richard Pulik - Officer Option exercise Stock Option (Right to Buy) 260,000 $0.00 -
Dec 23, 2025 EV Eric Venker - Officer Option exercise Common Shares 313,841 $3.85 $1.21M
Dec 24, 2025 EV Eric Venker - Officer Option exercise Common Shares 117,848 $3.85 $454K
Dec 23, 2025 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $22.45 $4.49M
Dec 24, 2025 EV Eric Venker - Officer Open-market sale Common Shares 75,000 $22.53 $1.69M
Dec 23, 2025 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 313,841 $0.00 -
Dec 24, 2025 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 117,848 $0.00 -
Dec 20, 2025 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares 2,129 $22.41 $48K
Dec 17, 2025 MS Mayukh Sukhatme - Officer Option exercise Common Shares 59,513 $12.68 $755K
Dec 17, 2025 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 26,831 $23.09 $620K
Dec 17, 2025 MS Mayukh Sukhatme - Officer Option exercise Common Shares 59,513 $0.00 -
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Common Shares 234,096 $4.06 $950K
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Common Shares 1,363,711 $12.68 $17.29M
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Common Shares 2,272,852 $12.68 $28.82M
Dec 15, 2025 MG Matthew Gline - Officer Open-market sale Common Shares 230,357 $21.68 $4.99M
Dec 15, 2025 MG Matthew Gline - Officer Other Common Shares 3,739 $21.68 $81K
Dec 15, 2025 MG Matthew Gline - Officer Open-market sale Common Shares 566,116 $21.68 $12.27M
Dec 15, 2025 MG Matthew Gline - Officer Other Common Shares 797,595 $21.68 $17.29M
Dec 15, 2025 MG Matthew Gline - Officer Open-market sale Common Shares 943,527 $21.68 $20.46M
Dec 15, 2025 MG Matthew Gline - Officer Other Common Shares 1,329,325 $21.68 $28.82M
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Stock Option (Right to Buy) 234,096 $0.00 -
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Stock Option (Right to Buy) 1,363,711 $0.00 -
Dec 15, 2025 MG Matthew Gline - Officer Option exercise Stock Option (Right to Buy) 2,272,852 $0.00 -
Aug 20, 2026 MAYUKH SUKHATME Officer, Director 17,519 $653K View on EDGAR
$IONS
IONIS PHARMACEUTICALS INC
